Investing Profile

David Goeddel

InvestorVC
Managing Partner at The Column Group
thecolumngroup.com/member/dav...Burlingame, California
Photo of David Goeddel, Managing Partner at The Column Group
Your Intro Paths to David Goeddel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find David Goeddel on

cb
Current Investing Position
The Column Group Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
19
Current Fund Size
$600M

David Goeddel is on these Sector & Stage Rankings

David Goeddel's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Hexagon Bio
Series BOct 2022$77M
Series UnknownSep 2021$61M
Series ASep 2020$47M
$190M
Co-investors: Alex Kolicich (8VC), Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures)
Peloton Therapeutics
Series EFeb 2019$150M
Series DSep 2016$52M
Series AJul 2011$18M
$280M
Co-investors: Derek DiRocco (RA Capital), Jim Tananbaum (Foresite Capital), Martin Alexander Gershon (Endeavor Venture Funds)
Exonics Therapeutics
Series ANov 2017$40M
$40M
NGM Biopharmaceuticals
Series DMar 2015$58M
Series BMar 2010$55M
Series ADec 2009$27M
$260M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences
Series BDec 2014$38M
$66M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Nurix Therapeutics
Series BMay 2014$25M
Series UnknownMar 2013$5M
SeedMay 2012$3M
$150M
Co-investors: Michael Rome (Foresite Capital)
Igenica
Series CJan 2014$14M
Series CJun 2012$33M
Series BJun 2010$24M
Series AJan 2009$3M
$74M
Co-investors: Richard Ulevitch (5am Ventures), Carl Gordon (OrbiMed)
Constellation Pharmaceuticals
Series CJan 2012$95M
$390M
Co-investors: Tony Evnin (Venrock), Robert Tepper (Third Rock Ventures), Brian Gallagher (Abingworth)